Loratadine and Pseudoephedrine Sulfate
NDC 37808-427, loratadine and pseudoephedrine sulfate, tablet, film coated, extended release, from HEB.
- Product NDC
- 37808-427
- Status
- Listed
- Labeler
- HEB
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA076557
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/37808-427 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LORATADINE10 mg/1
- PSEUDOEPHEDRINE SULFATE240 mg/1
Pharmacologic classes
Adrenergic alpha-Agonists [MoA]; alpha-Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 37808-427-69 | 37808042769 | 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (37808-427-69) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 37808-427 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/37808-427 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 37808-427. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.